Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cipla Ltd ( (IN:CIPLA) ) has issued an announcement.
Cipla Limited has announced the allotment of 2,853 equity shares under its Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021. This move increases the company’s issued, subscribed, and paid-up share capital to INR 1,61,55,08,148, reflecting its ongoing commitment to employee engagement and retention strategies.
More about Cipla Ltd
Cipla Ltd is a prominent pharmaceutical company based in India, known for its extensive range of medications and healthcare products. It primarily focuses on developing and manufacturing generic drugs and is a key player in the global pharmaceutical industry.
Average Trading Volume: 64,033
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1212.6B INR
See more insights into CIPLA stock on TipRanks’ Stock Analysis page.